Dear Friends of LRF,

Since its inception, one of the Lymphoma Research Foundation’s (LRF) guiding priorities has been pushing the field of lymphoma/chronic lymphocytic leukemia (CLL) forward toward a future free of the disease. It’s why we have funded over $76 million in lymphoma-specific research, which has led to crucial breakthroughs and cutting-edge treatments, and it is why we are committed to supporting the next generation of lymphoma researchers.

You will learn more about the brightest scientific minds committed to the study of this disease as we introduce you to our 2023 Clinical Investigator Career Development Award (CDA), Postdoctoral Fellowship, and Follicular Lymphoma Priority Research Grant grantees in this issue of Pulse. This distinguished group of researchers will help advance blood cancer research and lay the groundwork for improved patient care and breakthrough therapeutic methods. We are excited to witness the ways in which the work produced by these grantees will drive a deepened understanding of lymphoma and innovation toward a cure.

This issue also highlights an atypical path toward lymphoma research in our profile of Dr. Lindsay Morton, whose passion for epidemiology began during her undergraduate years with her work on a dolphin research study. Dr. Morton’s dedication as a member of our Scientific Advisory Board has informed our research portfolio and now a new effort focused on survivorship. Lastly, this issue features a dedicated group committed to supporting the lymphoma community as we celebrate the winners and nominees of our inaugural Fundraise Your Way awards. From bake sales to bike rides, these volunteers turn their talents and interests into one-of-a-kind fundraisers that power LRF’s mission.

The work that we do to invest in the future of lymphoma research and support our community of scientists, patients, survivors, and caregivers would not be possible without the steadfast dedication of our supporters. Your staunch commitment and your belief in the Foundation’s mission moves us closer every day to a future without lymphoma.